NCT04047810已完成1 期
A Pilot Study to Evaluate the Safety and Feasibility of Mesenchymal Stem Cells in the Treatment of Subjects With Advance Chronic Obstructive Pulmonary Disease (COPD)
适应症
干预措施
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- Mayo Clinic
- 入组人数
- 15
- 试验地点
- 1
- 主要终点
- Adverse Events
研究概览
简要总结
Researchers are trying to understand the effects of mesenchymal stem cells therapy in subjects with advance chronic obstructive pulmonary disease
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 90 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究组 & 干预措施
Subjects with Advanced Chronic Obstructive Pulmonary Disease
Experimental
Subjects diagnosed with severe or very severe COPD will be infused intravenously with Mesenchymal Stem Cells (MSC)
干预措施: Mesenchymal Stem Cells (Biological)
结局指标
主要结局
Adverse Events
时间窗: One hour post completion of infusion
Number of subjects to tolerate IV infusion of Mesenchymal Stem Cells (MSC) without acute clinical or physiological deterioration
次要结局
未报告次要终点
研究者
Jorge M Mallea
Principal Investigator
Mayo Clinic
研究点 (1)
Loading locations...
相似试验
已完成
1 期
Mesenchymal Stem Cells (MSCs) for Treatment of Acute Respiratory Distress Syndrome (ARD) in Patients With MalignanciesBlood And Marrow TransplantationAdult Respiratory Distress SyndromeNCT02804945M.D. Anderson Cancer Center20
Unknown
2 期
Efficacy and Safety Study of Allogenic Mesenchymal Stem Cells for Patients With Chronic Graft Versus Host DiseaseChronic Graft Versus Host DiseaseNCT01526850Chinese Academy of Medical Sciences100
已完成
1 期
Mesenchymal Stem Cell Therapy for Lung RejectionLung Transplant RejectBronchiolitis ObliteransNCT02181712Mayo Clinic19
撤回
1 期
Safety of Allogeneic Bone Marrow Derived Mesenchymal Stem Cells in Subjects With OsteoarthritisKnee OsteoarthritisNCT03602872Clinica Santa Clarita, Mexico
已完成
1 期
Repeated Infusions of Mesenchymal Stromal Cells in Children With Osteogenesis ImperfectaOsteogenesis Imperfecta Type IIOsteogenesis Imperfecta Type IIINCT01061099Nationwide Children's Hospital5